View in EDS

Parsonage-Turner Syndrome: An update

Saved in:
Bibliographic Details
Title: Parsonage-Turner Syndrome: An update
Authors: Amália Cinthia Meneses do Rêgo, Irami Araújo-Filho
Source: World Journal of Advanced Research and Reviews. 23:2882-2889
Publisher Information: GSC Online Press, 2024.
Publication Year: 2024
Subject Terms: Physiopathology, Diagnosis, Brachial Plexus Neuritis, Parsonage-Turner Syndrome, Therapy, Neuralgic Amyotrophy, 3. Good health
Description: Parsonage-Turner Syndrome (PTS), known as Neuralgic Amyotrophy or Brachial Plexus Neuritis, is a rare neurological disorder characterized by sudden onset shoulder pain followed by muscle weakness and atrophy. Despite advancements in medical research, the absence of standardized diagnostic and treatment protocols poses significant challenges. This review explores the multifaceted aspects of PTS, including its genetic predispositions, diagnostic advancements, treatment efficacy, and the long-term impacts on patients' quality of life. The heterogeneity of PTS presentations, the lack of specific biomarkers, and the unclear etiology contribute to the complexities in managing this condition. While current treatments vary from conservative to aggressive interventions, their efficacy remains inconsistent due to the syndrome's unpredictable prognosis. The disease's social and psychological impacts necessitate a comprehensive, multidisciplinary approach to patient care. This review underscores the need for further research to elucidate PTS's genetic and immunological underpinnings, develop more accurate diagnostic tools, and establish evidence-based treatment guidelines.
Document Type: Article
ISSN: 2581-9615
DOI: 10.30574/wjarr.2024.23.1.2253
DOI: 10.5281/zenodo.14830459
DOI: 10.5281/zenodo.14830460
Rights: CC BY
Accession Number: edsair.doi.dedup.....d78866d3555de5ea6d127d8d9d867fda
Database: OpenAIRE
Description
Abstract:Parsonage-Turner Syndrome (PTS), known as Neuralgic Amyotrophy or Brachial Plexus Neuritis, is a rare neurological disorder characterized by sudden onset shoulder pain followed by muscle weakness and atrophy. Despite advancements in medical research, the absence of standardized diagnostic and treatment protocols poses significant challenges. This review explores the multifaceted aspects of PTS, including its genetic predispositions, diagnostic advancements, treatment efficacy, and the long-term impacts on patients' quality of life. The heterogeneity of PTS presentations, the lack of specific biomarkers, and the unclear etiology contribute to the complexities in managing this condition. While current treatments vary from conservative to aggressive interventions, their efficacy remains inconsistent due to the syndrome's unpredictable prognosis. The disease's social and psychological impacts necessitate a comprehensive, multidisciplinary approach to patient care. This review underscores the need for further research to elucidate PTS's genetic and immunological underpinnings, develop more accurate diagnostic tools, and establish evidence-based treatment guidelines.
ISSN:25819615
DOI:10.30574/wjarr.2024.23.1.2253